找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Human Tumour Xenografts in Anticancer Drug Development; Benjamin Winograd,Michael Peckham,Herbert Michael Conference proceedings 1988 Spr

[復制鏈接]
查看: 51680|回復: 53
樓主
發(fā)表于 2025-3-21 20:03:26 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Human Tumour Xenografts in Anticancer Drug Development
編輯Benjamin Winograd,Michael Peckham,Herbert Michael
視頻videohttp://file.papertrans.cn/430/429563/429563.mp4
叢書名稱ESO Monographs
圖書封面Titlebook: Human Tumour Xenografts in Anticancer Drug Development;  Benjamin Winograd,Michael Peckham,Herbert Michael  Conference proceedings 1988 Spr
描述Starting in 1986, the European School of Oncology has expanded its activities in post- graduate teaching, which consisted mainly of traditional disease-orientated courses, by promoting new educational initiatives. One of these is the cloister seminars, short meet- ings intended for highly qualified oncologists and dealing with specific, controversial aspects of clinical practice and research. Another is the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on developments and treatment in specific fields of oncology. This series of ESO Monographs was designed with the specific purpose of disseminat- ing the results of the most interesting of the seminars and study groups, and providing concise and updated reviews of the subjects discussed. It was decided to keep the layout very simple in order to keep costs to a minimum and make the monographs available in the shortest possible time, thus overcoming a com- mon problem in medical literature: that of the material being outdated even before publication. Umberto Veronesi
出版日期Conference proceedings 1988
關鍵詞Antigen; biochemistry; carcinoma; interferon; transplantation
版次1
doihttps://doi.org/10.1007/978-3-642-73252-2
isbn_softcover978-3-642-73254-6
isbn_ebook978-3-642-73252-2
copyrightSpringer-Verlag Berlin Heidelberg 1988
The information of publication is updating

書目名稱Human Tumour Xenografts in Anticancer Drug Development影響因子(影響力)




書目名稱Human Tumour Xenografts in Anticancer Drug Development影響因子(影響力)學科排名




書目名稱Human Tumour Xenografts in Anticancer Drug Development網絡公開度




書目名稱Human Tumour Xenografts in Anticancer Drug Development網絡公開度學科排名




書目名稱Human Tumour Xenografts in Anticancer Drug Development被引頻次




書目名稱Human Tumour Xenografts in Anticancer Drug Development被引頻次學科排名




書目名稱Human Tumour Xenografts in Anticancer Drug Development年度引用




書目名稱Human Tumour Xenografts in Anticancer Drug Development年度引用學科排名




書目名稱Human Tumour Xenografts in Anticancer Drug Development讀者反饋




書目名稱Human Tumour Xenografts in Anticancer Drug Development讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:48:14 | 只看該作者
Representativity of Xenografts for Clinical Cancer. Tumor and Host Characteristics as Variables of Titution are factors of importance. Subcutaneous inoculation of tumor tissue is practical for most purposes, but “orthotopic” growth may be more clinically relevant for some tumors. New metastasis models have become available that permit biology and chemosensitivity studies to be performed under cond
板凳
發(fā)表于 2025-3-22 02:12:33 | 只看該作者
Comparison of Tumor Response in Nude Mice and in Patientsm. Xenografts enabled correct predictions for resistance in 96% and for tumor response in 90% of cases. Despite great efforts to obtain a large number of comparisons, only 32 test results were available before the patients needed treatment. Therefore, our study has shown that the xenograft system wi
地板
發(fā)表于 2025-3-22 08:06:59 | 只看該作者
Activity of Conventional Drugs in Head and Neck Cancer Xenograftstal dose was used. The activity of methotrexate in the nude mouse is less than can be expected from clinical studies. The mechanism responsible for this lack of activity is discussed in relation to our recent results.
5#
發(fā)表于 2025-3-22 09:32:02 | 只看該作者
6#
發(fā)表于 2025-3-22 15:25:18 | 只看該作者
7#
發(fā)表于 2025-3-22 19:20:13 | 只看該作者
8#
發(fā)表于 2025-3-22 22:42:21 | 只看該作者
B. J. M. Braakhuis,A. Leyva,H. M. Pinedo,G. B. Snow
9#
發(fā)表于 2025-3-23 03:25:36 | 只看該作者
10#
發(fā)表于 2025-3-23 06:50:08 | 只看該作者
Benjamin Winograd,Michael Peckham,Herbert Michael
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-14 13:38
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
林周县| 上虞市| 玉树县| 渭源县| 弋阳县| 栖霞市| 鹰潭市| 双城市| 黄陵县| 隆林| 兴山县| 岳阳市| 安陆市| 天镇县| 平果县| 陈巴尔虎旗| 类乌齐县| 珠海市| 图木舒克市| 靖安县| 化州市| 公主岭市| 苍梧县| 荥阳市| 大方县| 辉南县| 临沂市| 遵义县| 孟连| 涞源县| 旌德县| 崇州市| 中宁县| 都安| 布拖县| 宜兰县| 霸州市| 常州市| 临安市| 宜都市| 怀集县|